Tongdan Wang

503 total citations
21 papers, 392 citations indexed

About

Tongdan Wang is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Tongdan Wang has authored 21 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Nephrology and 3 papers in Surgery. Recurrent topics in Tongdan Wang's work include Ubiquitin and proteasome pathways (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Diabetes Treatment and Management (3 papers). Tongdan Wang is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Diabetes Treatment and Management (3 papers). Tongdan Wang collaborates with scholars based in China, New Zealand and United States. Tongdan Wang's co-authors include Jingwu Kang, Yingli Wu, Hanzhang Xu, Xia Li, Li‐Shun Wang, Guoqiang Chen, Chunmin Ma, Hu Lei, Weiwei Wang and Jian Zhang and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Chromatography A.

In The Last Decade

Tongdan Wang

21 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tongdan Wang China 12 242 64 56 37 37 21 392
Ye Shang China 13 147 0.6× 48 0.8× 28 0.5× 20 0.5× 32 0.9× 46 358
Xiaowan Han China 12 179 0.7× 33 0.5× 27 0.5× 17 0.5× 32 0.9× 33 346
Bernd Schneidinger Switzerland 5 227 0.9× 60 0.9× 26 0.5× 13 0.4× 28 0.8× 5 395
Joachim G. Müller United States 16 357 1.5× 52 0.8× 42 0.8× 15 0.4× 35 0.9× 23 791
Kazuyuki Kubota Japan 10 339 1.4× 43 0.7× 92 1.6× 11 0.3× 12 0.3× 14 586
Fabiana Crispo Italy 13 302 1.2× 96 1.5× 49 0.9× 58 1.6× 121 3.3× 23 504
Jochen Hochrein Germany 11 325 1.3× 49 0.8× 48 0.9× 3 0.1× 54 1.5× 14 495
Guo Li China 15 280 1.2× 126 2.0× 18 0.3× 9 0.2× 73 2.0× 27 639
Akira Takeyasu Japan 8 259 1.1× 79 1.2× 58 1.0× 27 0.7× 62 1.7× 8 453
Daniel C. Howey United States 16 270 1.1× 10 0.2× 43 0.8× 42 1.1× 28 0.8× 21 1.1k

Countries citing papers authored by Tongdan Wang

Since Specialization
Citations

This map shows the geographic impact of Tongdan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tongdan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tongdan Wang more than expected).

Fields of papers citing papers by Tongdan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tongdan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tongdan Wang. The network helps show where Tongdan Wang may publish in the future.

Co-authorship network of co-authors of Tongdan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Tongdan Wang. A scholar is included among the top collaborators of Tongdan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tongdan Wang. Tongdan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Tongdan, et al.. (2024). Drug deconjugation-assisted peptide mapping by LC–MS/MS to identify conjugation sites and quantify site occupancy for antibody-drug conjugates. Journal of Pharmaceutical and Biomedical Analysis. 243. 116098–116098. 6 indexed citations
2.
Zhou, Saijun, Yao Lin, Tongdan Wang, et al.. (2024). GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β‐Klotho‐Mediated Ferroptosis Inhibition. Advanced Science. 12(4). e2409781–e2409781. 10 indexed citations
3.
Shao, Xian, Yuling Zhang, Jiatong Li, et al.. (2024). An arterial spin labeling−based radiomics signature and machine learning for the prediction and detection of various stages of kidney damage due to diabetes. Frontiers in Endocrinology. 15. 1333881–1333881. 5 indexed citations
4.
Li, Qiuhong, Tongdan Wang, Xian Shao, et al.. (2024). Association of remnant cholesterol with renal function and its progression in patients with type 2 diabetes related chronic kidney disease. Frontiers in Endocrinology. 15. 1331603–1331603. 3 indexed citations
6.
Li, Qiuhong, Xian Shao, Zhuang Cui, et al.. (2022). Triglyceride-glucose index is significantly associated with the risk of hyperuricemia in patients with diabetic kidney disease. Scientific Reports. 12(1). 19988–19988. 16 indexed citations
7.
Zhou, Saijun, Yuling Zhang, Tongdan Wang, et al.. (2021). Canagliflozin could improve the levels of renal oxygenation in newly diagnosed type 2 diabetes patients with normal renal function. Diabetes & Metabolism. 47(5). 101274–101274. 17 indexed citations
8.
Jiang, Haiming, Kun Song, Tongdan Wang, et al.. (2017). A novel allosteric site in casein kinase 2α discovered using combining bioinformatics and biochemistry methods. Acta Pharmacologica Sinica. 38(12). 1691–1698. 19 indexed citations
9.
Wang, Weiwei, Hu Lei, Hao Luo, et al.. (2016). CDDO-Me reveals USP7 as a novel target in ovarian cancer cells. Oncotarget. 7(47). 77096–77109. 46 indexed citations
11.
Wei, Wei, Chunmin Ma, Yang Cao, et al.. (2015). Identification of H7 as a novel peroxiredoxin I inhibitor to induce differentiation of leukemia cells. Oncotarget. 7(4). 3873–3883. 19 indexed citations
12.
Zhang, Yu, et al.. (2014). 2-Methoxyestradiol deficiency is strongly related to hypertension in early onset severe pre-eclampsia. Pregnancy Hypertension. 4(3). 215–219. 13 indexed citations
13.
Wang, Tongdan, Qianqian Zhang, Yanmei Zhang, & Jingwu Kang. (2014). Screening of protein kinase inhibitors in natural extracts by capillary electrophoresis combined with liquid chromatography–tandem mass spectrometry. Journal of Chromatography A. 1337. 188–193. 25 indexed citations
14.
Zhang, Xuepei, Tongdan Wang, Hanzhi Zhang, et al.. (2014). Profiling of drug binding proteins by monolithic affinity chromatography in combination with liquid chromatography–tandem mass spectrometry. Journal of Chromatography A. 1359. 84–90. 6 indexed citations
15.
Wu, Zhaoxia, Meng Zhao, Xia Li, et al.. (2013). PKCδ enhances C/EBPα degradation via inducing its phosphorylation and cytoplasmic translocation. Biochemical and Biophysical Research Communications. 433(2). 220–225. 3 indexed citations
16.
Li, Xia, Tongdan Wang, Shao-Ming Shen, et al.. (2013). Phosphoproteomics Study on the Activated PKCδ-Induced Cell Death. Journal of Proteome Research. 12(10). 4280–4301. 8 indexed citations
17.
Wang, Tongdan, Chao Liu, Qianqian Zhang, et al.. (2013). Drug Target Identification Using Affinity Core‐Shell Magnetic Nanoparticles and Mass Spectrometry. Chinese Journal of Chemistry. 31(6). 715–720. 6 indexed citations
18.
Liu, Bin, Ying Zheng, Tongdan Wang, et al.. (2012). Proteomic Identification of Common SCF Ubiquitin Ligase FBXO6-Interacting Glycoproteins in Three kinds of Cells. Journal of Proteome Research. 11(3). 1773–1781. 33 indexed citations
19.
Wang, Tongdan & Jingwu Kang. (2009). Hexokinase inhibitor screening based on adenosine 5′‐diphosphate determination by electrophoretically mediated microanalysis. Electrophoresis. 30(8). 1349–1354. 25 indexed citations
20.
Wang, Tongdan, et al.. (2007). Immobilized capillary enzyme reactor based on layer‐by‐layer assembling acetylcholinesterase for inhibitor screening by CE. Electrophoresis. 28(17). 2981–2987. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026